Get notified when USPH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsUSPH Q2 2026: Revenue +8.5% to $214.1M, EPS -19.5% to $0.25 on margin pressure
Filed August 7, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 8, 2025 · ~1 min read
Key Changes
-
high
Two new 10-year hospital affiliation agreements announced in early 2026 will integrate 70 clinics (60 Metro clinics in New York and 10 at another subsidiary) into hospital systems' clinical networks, with integrations underway through Q3 2026. This expands the hospital-affiliated revenue model significantly.
MD&A: Hospital Affiliations verify on EDGAR → -
high
The refinancing adds $125M in borrowing capacity and extends maturity by ~4 years, supporting acquisition and growth plans.
MD&A: Credit Facility verify on EDGAR → -
high
The program is nearly complete, representing significant capital return alongside a 2.2% dividend increase to $0.46/share.
MD&A: Share Repurchase verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (INFQ 10-Q) is open in full — no account needed.
Partner
Trade USPH commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 20, 2026 · How we verify